JPS6350343B2 - - Google Patents
Info
- Publication number
- JPS6350343B2 JPS6350343B2 JP58132645A JP13264583A JPS6350343B2 JP S6350343 B2 JPS6350343 B2 JP S6350343B2 JP 58132645 A JP58132645 A JP 58132645A JP 13264583 A JP13264583 A JP 13264583A JP S6350343 B2 JPS6350343 B2 JP S6350343B2
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- halogen
- compound
- nitrooxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8221592 | 1982-07-26 | ||
GB8221592 | 1982-07-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5951263A JPS5951263A (ja) | 1984-03-24 |
JPS6350343B2 true JPS6350343B2 (en, 2012) | 1988-10-07 |
Family
ID=10531922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58132645A Granted JPS5951263A (ja) | 1982-07-26 | 1983-07-19 | 硝酸ピリジルアルキルエステル化合物、その製造法およびそれを含有する医薬製剤 |
Country Status (17)
Country | Link |
---|---|
US (2) | US4540701A (en, 2012) |
EP (1) | EP0100081B1 (en, 2012) |
JP (1) | JPS5951263A (en, 2012) |
KR (1) | KR900005470B1 (en, 2012) |
AT (1) | ATE40948T1 (en, 2012) |
AU (1) | AU565791B2 (en, 2012) |
CA (1) | CA1216850A (en, 2012) |
DE (1) | DE3379255D1 (en, 2012) |
DK (1) | DK311683A (en, 2012) |
ES (1) | ES8502088A1 (en, 2012) |
FI (1) | FI832490A7 (en, 2012) |
GR (1) | GR78629B (en, 2012) |
HU (1) | HU190497B (en, 2012) |
NO (1) | NO832700L (en, 2012) |
PH (1) | PH18083A (en, 2012) |
SU (1) | SU1189337A3 (en, 2012) |
ZA (1) | ZA835048B (en, 2012) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6081166A (ja) * | 1983-10-11 | 1985-05-09 | Fujisawa Pharmaceut Co Ltd | 2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法 |
JPS6215A (ja) * | 1985-02-26 | 1987-01-06 | Fujisawa Pharmaceut Co Ltd | 2−ニトロオキシメチル−6−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤 |
ZA885069B (en) * | 1987-07-24 | 1989-03-29 | Fujisawa Pharmaceutical Co | Sustained-release percutaneous preparations |
JPH02167279A (ja) * | 1988-09-30 | 1990-06-27 | Taisho Pharmaceut Co Ltd | アポビンカミン酸誘導体 |
US5047543A (en) * | 1988-11-24 | 1991-09-10 | Taisho Pharmaceutical Co., Ltd. | 1,4-dihydropyridine derivatives |
CN106318877A (zh) * | 2016-08-29 | 2017-01-11 | 刘翔 | 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3275642A (en) * | 1962-04-26 | 1966-09-27 | Bard Pharmaceutical Inc | 3-pyridine carbinol nitrate and its preparation |
US3689494A (en) * | 1971-03-31 | 1972-09-05 | William R J Simpson | N-pyridinealkyl-alkanolamine nitrates |
-
1983
- 1983-07-05 DK DK311683A patent/DK311683A/da not_active Application Discontinuation
- 1983-07-07 AU AU16635/83A patent/AU565791B2/en not_active Ceased
- 1983-07-07 FI FI832490A patent/FI832490A7/fi not_active Application Discontinuation
- 1983-07-11 GR GR71903A patent/GR78629B/el unknown
- 1983-07-11 ZA ZA835048A patent/ZA835048B/xx unknown
- 1983-07-19 JP JP58132645A patent/JPS5951263A/ja active Granted
- 1983-07-20 PH PH29255A patent/PH18083A/en unknown
- 1983-07-20 US US06/515,653 patent/US4540701A/en not_active Expired - Fee Related
- 1983-07-22 ES ES524375A patent/ES8502088A1/es not_active Expired
- 1983-07-23 AT AT83107232T patent/ATE40948T1/de not_active IP Right Cessation
- 1983-07-23 EP EP83107232A patent/EP0100081B1/en not_active Expired
- 1983-07-23 DE DE8383107232T patent/DE3379255D1/de not_active Expired
- 1983-07-25 HU HU832615A patent/HU190497B/hu unknown
- 1983-07-25 SU SU833625197A patent/SU1189337A3/ru active
- 1983-07-25 NO NO832700A patent/NO832700L/no unknown
- 1983-07-26 KR KR1019830003459A patent/KR900005470B1/ko not_active Expired
- 1983-07-26 CA CA000433162A patent/CA1216850A/en not_active Expired
-
1985
- 1985-05-08 US US06/731,893 patent/US4613608A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0100081A2 (en) | 1984-02-08 |
NO832700L (no) | 1984-02-06 |
DE3379255D1 (en) | 1989-04-06 |
ES524375A0 (es) | 1984-12-16 |
DK311683D0 (da) | 1983-07-05 |
EP0100081A3 (en) | 1985-05-02 |
FI832490L (fi) | 1984-01-27 |
FI832490A7 (fi) | 1984-01-27 |
DK311683A (da) | 1984-01-27 |
ES8502088A1 (es) | 1984-12-16 |
SU1189337A3 (ru) | 1985-10-30 |
US4540701A (en) | 1985-09-10 |
KR840005426A (ko) | 1984-11-12 |
AU565791B2 (en) | 1987-10-01 |
FI832490A0 (fi) | 1983-07-07 |
CA1216850A (en) | 1987-01-20 |
PH18083A (en) | 1985-03-18 |
EP0100081B1 (en) | 1989-03-01 |
KR900005470B1 (ko) | 1990-07-30 |
ZA835048B (en) | 1984-03-28 |
US4613608A (en) | 1986-09-23 |
AU1663583A (en) | 1984-02-02 |
GR78629B (en, 2012) | 1984-09-27 |
ATE40948T1 (de) | 1989-03-15 |
JPS5951263A (ja) | 1984-03-24 |
HU190497B (en) | 1986-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6489338B2 (en) | Imidazopyridine and imidazopyrimidine antiviral agents | |
EP1309594B1 (fr) | Derives de benzimidazole, leur preparation et leur application en therapeutique | |
WO1995028387A1 (fr) | Compose benzamide et utilisation medicale dudit compose | |
KR20090106633A (ko) | PDE5 억제제로서 유용한 6-벤질-2,3,4,7-테트라히드로-인돌로[2,3-c]퀴놀린 화합물 | |
WO2010131663A1 (ja) | オキサミド誘導体 | |
FR2917412A1 (fr) | Derives de 7-alkynyl, 1,8-naphthyridones, leur preparation et leur application en therapeutique | |
FR2566404A1 (fr) | Nouveaux derives de la 1,4-dihydropyridine, leurs sels, procede pour les preparer, et compositions pharmaceutiques les contenant | |
JPS62149662A (ja) | N−含有複素環化合物 | |
KR850000626B1 (ko) | 시클로헥센 유도체의 제조방법 | |
WO2018041260A1 (zh) | 一类溴结构域识别蛋白抑制剂及其制备方法和用途 | |
JPS6350343B2 (en, 2012) | ||
US5446050A (en) | Azabicyclo amides and esters as 5-HT3 receptor antagonists | |
JPS6330908B2 (en, 2012) | ||
EP1339719B1 (fr) | Derives de benzimidazole, leur preparation et leur application en therapeutique | |
EP0312040B1 (en) | 2,4-disubstituted derivatives of tetrahydrofuran | |
FR2911605A1 (fr) | Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique | |
JPS6115875B2 (en, 2012) | ||
WO2006027366A1 (en) | 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity | |
US7338964B2 (en) | 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity | |
JPS5910358B2 (ja) | 新規エルゴリン誘導体 | |
JPH037279A (ja) | 2―チオピランカルボチオアミド誘導体 | |
JPH035456A (ja) | 2―置換アルキル―1,4―ジヒドロピリジン―3,5―ジカルボン酸ジエステル誘導体およびその製法 | |
JPS61249982A (ja) | エブルナメニン誘導体の製造方法 | |
JPH04257581A (ja) | ピペリジノメチルピリジン誘導体 | |
JPH01104046A (ja) | 1,4−ジヒドロピリジン誘導体、その製造方法およびそれを有効成分とする薬剤 |